跳至主要内容
临床试验/NCT01533844
NCT01533844终止不适用

An Observational, Non-interventional Study to Determine the Role of Clostridium Difficile in the Pathogenesis of Disease Observed in Neonates and to Investigate the Feasibility of a Potential Study to Evaluate Safety, Efficacy and Pharmacokinetics of Fidaxomicin Oral Suspension in Neonates With Clostridium Difficile Associated Disease (CDAD)

Astellas Pharma Europe B.V.9 个研究点 分布在 4 个国家目标入组 1 人开始时间: 2012年3月最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
1
试验地点
9
主要终点
To determine the feasibility of a potential interventional study with fidaxomicin

研究概览

简要总结

The objective of this multi-center, prospective observational study is to determine the feasibility of a potential interventional study with fidaxomicin. The incidence and clinical aspects of Clostridium difficile infection (CDI) in neonates will be determined, and it will be assessed whether a subgroup can be identified where treatment with fidaxomicin therapy might improve outcome.

研究设计

研究类型
Observational
时间视角
Prospective

入排标准

年龄范围
— 至 27 Days(Child)
性别
All
接受健康志愿者

入选标准

  • Subject is suffering from diarrhea or other signs or symptoms consistent with CDAD (as described in section 5.2.3)
  • Presence of either toxin A or B (or both) of C. difficile in the stool within 24 hours prior to enrollment using the C. difficile Quik Chek Complete® diagnostic test, provided by the sponsor

排除标准

  • Subject will be excluded from participation if any of the following apply:
  • Preterm neonates
  • Negative C. difficile toxin test

结局指标

主要结局

To determine the feasibility of a potential interventional study with fidaxomicin

时间窗: 40 days

The incidence and clinical aspects of clostridium difficile infection (CDI) in neonates will be determined, and it will be assessed whether a subgroup can be identified where treatment with fidaxomicin therapy might improve outcome.

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (9)

Loading locations...

相似试验